Inhibition of Angiopoietin-Like 3 (ANGPTL3) Reduces Adipose Tissue Insulin Resistance in Patients With Familial Partial Lipodystrophy

por de Freitas, Maria Cristina Foss, Akinci, Baris, Neidert, Adam, Hench, Rita, Oral, Elif A
Publicado 2021

2287 ECG and echo characteristics in familial partial lipodystrophy: The impact of Lamin A variants

por Eldin, Abdelwahab J., Meral, Rasimcan, Neidert, Adam H., Rus, Diana, Hench, Rita, Oral, Hakan, Oral, Elif A.
Publicado 2018

Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to Metreleptin

por Esfandiari, Nazanene H., Rubenfire, Melvyn, Neidert, Adam H., Hench, Rita, Eldin, Abdelwahab Jalal, Meral, Rasimcan, Oral, Elif A.
Publicado 2019

The Peroxisome Proliferator Activated Receptor‐γ Pioglitazone Improves Vascular Function and Decreases Disease Activity in Patients With Rheumatoid Arthritis

por Marder, Wendy, Khalatbari, Shokoufeh, Myles, James D., Hench, Rita, Lustig, Susan, Yalavarthi, Srilakshmi, Parameswaran, Aishwarya, Brook, Robert D., Kaplan, Mariana J.
Publicado 2013

MON-101 The LD Lync Study: Natural History Study of Lipodystrophy Syndromes: Early Lessons from the Pilot Data

por Jalal Eldin, Abdelwahab, Akinci, Baris, Meral, Rasimcan, Rus, Diana, Swaidan, Mario, Hench, Rita, Neidert, Adam, Stratton, Andra, Spino, Cathie, Oral, Elif
Publicado 2019

OR33-02 The Treatment of Partial Lipodystrophy in the Setting of Neutralizing Antibody Against Metreleptin with Leptin Receptor Agonist REGN4461

por Akinci, Baris, de Freitas, Maria Cristina Foss, Baker, Mark, Hench, Rita, Neidert, Adam, Boutros, Sabine, Akinci, Efe Yagiz, Oral, Elif A
Publicado 2020

The complicated clinical course in a case of atypical lipodystrophy after development of neutralizing antibody to metreleptin: treatment with setmelanotide

por Akinci, Baris, Meral, Rasimcan, Rus, Diana, Hench, Rita, Neidert, Adam H, DiPaola, Frank, Westerhoff, Maria, Taylor, Simeon I, Oral, Elif A
Publicado 2020

SUN-607 Iron Parameters in Patients with Partial Lipodystrophy and Impact of Metreleptin Therapy

por Boutros, Sabine, Akinci, Efe Yagiz, Ryan, Benjamin, Sargin, Pinar, Akinci, Baris, Swaidan, Mario, Neidert, Adam, Hench, Rita, Horowitz, Jeffrey, Oral, Elif A
Publicado 2020

OR17-02 Changes in Hepatokines and Apolipoproteins Are Associated with Metabolic Response to Metreleptin in Partial Lipodystrophy

por Akinci, Baris, Ajluni, Nevin, Eldin, Abdelwahab Jalal, Swaidan, Mario, Hench, Rita, Neidert, Adam, Luo, Yingying, de Freitas, Maria Cristina Foss, Oral, Elif A
Publicado 2020

Iron parameters in patients with partial lipodystrophy and impact of exogenous leptin therapy

por Akinci, Efe Y, Boutros, Sabine, Ryan, Benjamin J, Sargin, Pinar, Akinci, Baris, Neidert, Adam H, Hench, Rita, Horowitz, Jeffrey F, Oral, Elif A
Publicado 2021

MON-121 Pain Is a Major Driver of Quality of Life and Psychoemotional Health in Lipodystrophy Syndromes

por Eldin, Abdelwahab Jalal, Akinci, Baris, Luo, Yingying, de Freitas, Maria Cristina Foss, Swaidan, Mario, Meral, Rasimcan, Rus, Diana, Hench, Rita, Neidert, Adam, Stratton, Andra, Spino, Cathie, Clauw, Daniel, Oral, Elif A
Publicado 2020

SUN-556 Cardiac Phenotype in Familial Partial Lipodystrophy

por Eldin, Abdelwahab Jalal, Akinci, Baris, da Rocha, Andre Monteiro, Meral, Rasimcan, Simsir, Ilgin Yildirim, Adiyaman, Suleyman Cem, Ozpelit, Ebru, Bhave, Nicole, Gen, Ramazan, Yurekli, Banu Sarer, Kutbay, Nilufer Ozdemir, Siklar, Zeynep, Neidert, Adam, Swaidan, Mario, Rus, Diana, Hench, Rita, Jalife, Jose, Oral, Hakan, Oral, Elif A
Publicado 2020